Pharmacology Drug Cards: Aspirin, Acetaminophen, NSAIDs, and Gout

Drug Card Template Overview

• When discussing a new drug, use the flashcard/drug card format

• Top section includes: drug name or family, prototype, generic name, brand name (brand in parentheses), mechanism of action, uses, nursing considerations

• Prototype: the representative drug for a class or family; may be the first of its type or most commonly used

• Brand name included for completion; tests focus on generic name

• Mechanism of action (MOA): what the drug does in the body to achieve its therapeutic effect

• Uses: what the drug is used to treat

• Nursing considerations: key safety, monitoring, and administration notes; color coding (red = important adverse effects; blue = unique protective effects)

• Note: dosing details may be emphasized for certain drugs where dose determines indication

• Use the format to guide test prep and clinical reasoning

Salicylates: Aspirin (Prototype)

• MOA: Inhibits prostaglandin synthesis and thromboxane A2 production; leads to decreased platelet aggregation

• Uses: Mild to moderate pain relief; reduced cardiac risk due to antiplatelet effect

• Dosing concepts

  • Low dose (often 81\,\text{mg}, “baby aspirin”) used for cardiac risk reduction (antiplatelet effect)

  • Higher doses more commonly used for pain relief (today, NSAIDs or Tylenol more commonly used for pain)

  • This dosing distinction helps determine indication

• Important safety/monitoring

  • Primary adverse effect: GI bleeding (increased bleeding risk with any antiplatelet/blood thinner activity)

  • NSAIDs and aspirin can irritate GI tract, increasing GI bleed risk

  • Salicylism (rare, long-term high-dose toxicity): tinnitus, dizziness, hearing difficulty, confusion

  • Reye’s syndrome (encephalopathy) risk in anyone age 18 or younger; avoid giving aspirin to this age group for pain/fever

  • GI bleeding signs to monitor: vomiting blood; black, tarry stools due to digested blood

  • Hold before surgery: timing varies by surgeon; common practice is to hold for about 7\text{ days} prior to surgery; some cases may resume soon after surgery depending on procedure

• Practical nursing considerations

  • Give with food to reduce GI upset

  • Discuss perioperative holding with the surgical team

  • Potential perioperative planning around bleeding risk

• Overdose/poisoning management (general concepts for oral agents)

  • If overdose suspected: stomach lavage (gastric lavage), activated charcoal, hemodialysis (in severe cases)

• Other notes

  • Both aspirin and other NSAIDs can raise GI bleeding risk and irritation; be mindful of concomitant NSAID use

  • Red flags in patient education: GI symptoms, tinnitus, signs of bleeding, and avoidance of use in certain age groups

• Signs of GI bleeding (quick recap):

  • Petechiae and easy bruising (bleeding tendencies)

  • Hematemesis (vomiting blood) or hematochezia/melena (blood in stool, stool that is black or tarry)

• Summary for test readiness

  • Know that low-dose aspirin ≈ cardiac risk reduction; high-dose aspirin ≈ pain relief

  • GI bleeding and salicylism are key adverse effects to monitor

  • Avoid aspirin in patients ≤18 years old due to Reye’s syndrome risk

Tylenol (Acetaminophen)

• Brand names: Tylenol; IV version: Ofirmev

• MOA: Acts on the hypothalamus to reduce fever and relieve mild pain

• Uses: Treats mild pain and fever; not an NSAID, with a different side-effect profile

• Safety and monitoring

  • Main risk: hepatotoxicity, especially with higher doses or chronic use

  • Liver function tests (LFTs): AST and ALT elevated indicate hepatotoxicity

  • Alcohol use increases risk of toxic metabolite production; avoid high-risk alcohol use with acetaminophen

• Dosing considerations

  • Max daily dose: 4\ \text{grams/day} (primary safety guideline)

  • Pediatric dosing can be confusing due to multiple OTC formulations; confirm concentration and dosing per weight/age

  • Problematic in multi-symptom OTC products: many cold/flu products include acetaminophen; read labels to avoid inadvertent overdose

• Antidote for overdose

  • Acetylcysteine is the antidote (name similarity helps remember: acetaminophen ↔ acetylcysteine)

• Liver toxicity signs

  • Jaundice (yellowing of skin/eyes) as a key sign of severe hepatotoxicity

• Special considerations

  • Alcohol abuse elevates risk of acetaminophen toxicity due to altered metabolism

• Quick educational points from case context

  • Accidental overdose risk via combination OTC products is high; always check labels for acetaminophen content in each product

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

• Two broad categories

  • Nonselective NSAIDs (COX-1 and COX-2 inhibitors)

  • COX-2 selective NSAIDs (e.g., celecoxib)

• Mechanism overview

  • Both categories reduce prostaglandin synthesis, thereby decreasing inflammation and pain

  • Nonselective NSAIDs block both COX-1 and COX-2; COX-1 is involved in GI protection and platelet aggregation; COX-2 drives inflammation

  • COX-2 selective drugs aim to preserve COX-1 GI protection while reducing inflammation

• Nonselective NSAIDs: examples and notes

  • Ibuprofen (Brand: Motrin, Advil): commonly used for pain relief; also used in arthritis and gout attacks

  • Black box warnings: increased risk of cardiovascular events (due to effects on platelet function/vascular homeostasis) and GI bleeding risk

  • Other nonselective NSAIDs: meloxicam, indomethacin, ketorolac (Toradol)

  • Indomethacin: available as an injection; used to close patent ductus arteriosus (PDA) in premature infants

  • Ketorolac (Toradol): potent analgesic; available orally but notably potent in IV form; generally limited to about 5\text{ days} of use due to safety concerns

• COX-2 selective NSAIDs

  • Celecoxib: selective for COX-2; intended to reduce GI bleeding risk and preserve GI protective effects of COX-1

  • Real-world limitations: risks (including cardiovascular events) still present, though some data suggest lower GI toxicity; not completely free of adverse effects

  • Practical use: may be chosen for chronic arthritis when GI risk is a concern, but monitor cardiovascular risk factors

• Special clinical notes

  • Celecoxib retains some protective COX-1 effects but the balance of risks remains; not universally safer for all patients

  • When a patient is on anticoagulants or strong blood thinners, NSAID use requires caution due to bleeding risk

  • In perioperative settings, NSAID use may be paused due to bleeding risk; coordination with surgical team is essential

• Gout-related note on NSAIDs (contextual)

  • NSAIDs can be used to treat acute gout flares due to anti-inflammatory effects; colchicine and allopurinol are also used for gout management (see separate gout section)

Gout Treatments

• Pathophysiology recap

  • Hyperuricemia with urate crystal deposition in joints; most classic site is the big toe; crystals can form tophi; progression has stages from mild joint pain to intense pain and chronic deposits

• Colchicine (Colcrys) – acute gout management

  • MOA: Inhibits white blood cell migration into areas with urate crystals; reduces inflammatory response without being an NSAID

  • Use: Effective for acute gout attacks; anti-inflammatory effect targeted to gout pathology

• Allopurinol – prevention of gout attacks

  • MOA: Decreases uric acid production; helps prevent future attacks when used between flares

  • Hydration note: Increasing uric acid excretion in the urine can lead to uric acid kidney stones; stay well hydrated to help flush stones and crystals

  • Contraindication highlighted in material: family history of hemochromatosis (iron overload) is listed as a contraindication in this source

  • Important teaching point: Allopurinol is preventive, not for acute flare treatment; monitor for kidney stone symptoms and ensure hydration

• Case-study style teaching points

  • Acute gout flare with family history of hemochromatosis: Colchicine preferred for acute management; Allopurinol contraindicated in this specific contraindication scenario per the material

  • Select all that apply exercise suggests: Colchicine (acute flare) and Allopurinol contraindication due to hemochromatosis can be correct teaching points

Case Studies, Questions, and Practical Applications (From the Transcript)

• Case question 1 (GI bleed + prior OTC pain med with unknown name): best pain treatment choice

  • Reasoning: Mild pain generally not treated with opioids like morphine; GI bleeding risk points toward avoiding NSAIDs and aspirin; acetaminophen is the safest nonprescription analgesic in the context of GI bleeding, hence acetaminophen is selected

• Case question 2 (education after not taking the drug): accurate education statement

  • Transcript indicates the correct choice is option B (as discussed in the session): the drug is acetaminophen; avoid unsafe combinations; remember maximum daily dose; alcohol and liver toxicity risk; recognize toxicity signs (e.g., jaundice) and consider interaction with alcohol

  • The other options: aspirin-related dosing (81 mg) and alcohol safety for acetaminophen are not accurate if presented as described in the example

• Case question 3 (drug causing GI bleeding symptoms)

  • Answer: ibuprofen (a nonselective NSAID) is most likely responsible for vomiting blood and blood in stool; celecoxib (COX-2 selective) carries lower risk for these GI bleeding symptoms, matching the discussion

• Gout brief exercise

  • Acute gout flare management: Colchicine is preferred for acute flares; Allopurinol is preventive but contraindicated in the presented hemochromatosis history scenario according to the given material

Practical and Review Connections

• Core pharmacology concepts linked to these notes

  • COX pathways: COX-1 provides GI protection and platelet aggregation; COX-2 drives inflammation and pain

  • Nonselective NSAIDs affect both COX-1 and COX-2, increasing GI bleeding and cardiovascular risk; COX-2 selective agents aim to reduce those GI risks but carry cardiovascular considerations

  • Prodrug and metabolite considerations: acetaminophen safety hinges on hepatic metabolism; alcohol interaction shifts pathways toward toxic metabolites

• Real-world relevance

  • Pain management often starts with acetaminophen or NSAIDs; prophylaxis of cardiac risk with low-dose aspirin involves balancing antiplatelet benefit against bleeding risk and perioperative planning

  • Gout management requires understanding both acute and preventive strategies; hydration and kidney stone risk are important in prevention strategies

• Ethical/philosophical/practical implications

  • Balancing effective pain relief with risk of addiction (especially with opioids) and adverse events (GI bleeding, hepatotoxicity) is a central clinical ethical concern

  • The importance of patient education on OTC medications, label reading, and avoiding polypharmacy to prevent unintended overdoses and complications

• Formulas and numeric references (LaTeX)

  • Low-dose aspirin: 81\ \text{mg} for cardiac risk reduction

  • Acetaminophen maximum daily dose: 4\ \text{g/day}

  • Ketorolac (Toradol) usage limit: up to 5\ \text{days}

  • Perioperative holding of aspirin: commonly around 7\ \text{days} prior to surgery (timing varies by surgeon)

  • Major drug names and associations: Acetaminophen antidote = acetylcysteine; Prostaglandin pathway involvement summarized in MOA statements

Summary Takeaways for Exam Prep

• Aspirin (Salicylate): MOA involves prostaglandin and thromboxane A2 inhibition; low-dose for cardiac risk; watch for GI bleeding and Reye’s (misnamed as Ray’s) syndrome in those ≤18; dosing around 81\ \text{mg} for heart protection; higher doses for pain; perioperative holding commonly ~7\text{ days} prior

• Acetaminophen (Tylenol): Mechanism via hypothalamic action; safe GI profile but hepatotoxic at high doses or with alcohol; Max daily dose 4\ \text{g/day}; antidote = acetylcysteine; read OTC labels thoroughly to avoid hidden acetaminophen combinations

• NSAIDs: Nonselective (COX-1 & COX-2) and COX-2 selective (celecoxib)

  • Nonselective: ibuprofen (Motrin/Advil) with CV and GI bleeding risks; other agents include meloxicam, indomethacin (injection for PDA in preemies), ketorolac (Toradol) with a 5-day use limit

  • COX-2 selective: celecoxib offers reduced GI risk but still carries cardiovascular risk; not a complete safety solution

• Gout treatments: Colchicine for acute flares; Allopurinol for prevention but watch for contraindications (as described in the material, including a hemochromatosis history); hydration is important to minimize uric acid stone risk

• Test-question patterns to expect

  • Identify safest analgesic in a GI bleed scenario (often acetaminophen)

  • Distinguish between acute (colchicine) versus preventive (allopurinol) gout therapies

  • Recognize nonselective NSAIDs as higher risk for GI bleeding and CV events compared to COX-2 selective agents, with caveats

  • Be prepared for scenario-based questions about perioperative management and drug interactions (especially OTC components containing acetaminophen)